These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31544845)

  • 1. Dynamic Views of the Fc Region of Immunoglobulin G Provided by Experimental and Computational Observations.
    Yanaka S; Yogo R; Inoue R; Sugiyama M; Itoh SG; Okumura H; Miyanoiri Y; Yagi H; Satoh T; Yamaguchi T; Kato K
    Antibodies (Basel); 2019 Jul; 8(3):. PubMed ID: 31544845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa.
    Sakae Y; Satoh T; Yagi H; Yanaka S; Yamaguchi T; Isoda Y; Iida S; Okamoto Y; Kato K
    Sci Rep; 2017 Oct; 7(1):13780. PubMed ID: 29062024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical characterization of dynamic structures of immunoglobulin G.
    Yanaka S; Yogo R; Kato K
    Biophys Rev; 2020 Jun; 12(3):637-645. PubMed ID: 32410186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
    Falconer DJ; Subedi GP; Marcella AM; Barb AW
    ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.
    Isoda Y; Yagi H; Satoh T; Shibata-Koyama M; Masuda K; Satoh M; Kato K; Iida S
    PLoS One; 2015; 10(10):e0140120. PubMed ID: 26444434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR assignments of the N-glycans of the Fc fragment of mouse immunoglobulin G2b glycoprotein.
    Yanaka S; Yamaguchi Y; Takizawa T; Miyanoiri Y; Yogo R; Shimada I; Kato K
    Biomol NMR Assign; 2021 Apr; 15(1):187-192. PubMed ID: 33423189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
    Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
    Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational Plasticity of the Immunoglobulin Fc Domain in Solution.
    Remesh SG; Armstrong AA; Mahan AD; Luo J; Hammel M
    Structure; 2018 Jul; 26(7):1007-1014.e2. PubMed ID: 29731233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms.
    Cambay F; Forest-Nault C; Dumoulin L; Seguin A; Henry O; Durocher Y; De Crescenzo G
    Mol Immunol; 2020 May; 121():144-158. PubMed ID: 32222585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C
    Yageta S; Imamura H; Shibuya R; Honda S
    MAbs; 2019 Apr; 11(3):453-462. PubMed ID: 30513259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of N-Glycan Composition on Structure and Dynamics of IgG1 Fc and Their Implications for Antibody Engineering.
    Lee HS; Im W
    Sci Rep; 2017 Oct; 7(1):12659. PubMed ID: 28978918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
    Ahmed AA; Keremane SR; Vielmetter J; Bjorkman PJ
    J Struct Biol; 2016 Apr; 194(1):78-89. PubMed ID: 26850169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and Dynamics of Immunoglobulin G Glycoproteins.
    Yagi H; Yanaka S; Kato K
    Adv Exp Med Biol; 2018; 1104():219-235. PubMed ID: 30484251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of deglycosylated human IgG1 shows the role of C
    Spiteri VA; Doutch J; Rambo RP; Gor J; Dalby PA; Perkins SJ
    Biophys J; 2021 May; 120(9):1814-1834. PubMed ID: 33675758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy.
    Yamaguchi Y; Nishimura M; Nagano M; Yagi H; Sasakawa H; Uchida K; Shitara K; Kato K
    Biochim Biophys Acta; 2006 Apr; 1760(4):693-700. PubMed ID: 16343775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Structure of a Homogeneous IgG-Fc Glycoform with the N-Glycan Designed to Maximize the Antibody Dependent Cellular Cytotoxicity.
    Chen CL; Hsu JC; Lin CW; Wang CH; Tsai MH; Wu CY; Wong CH; Ma C
    ACS Chem Biol; 2017 May; 12(5):1335-1345. PubMed ID: 28318221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional diversification of IgGs through Fc glycosylation.
    Wang TT; Ravetch JV
    J Clin Invest; 2019 Sep; 129(9):3492-3498. PubMed ID: 31478910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Fc-Glycan Structure on the Conformational Stability of IgG Revealed by Hydrogen/Deuterium Exchange and Limited Proteolysis.
    Fang J; Richardson J; Du Z; Zhang Z
    Biochemistry; 2016 Feb; 55(6):860-8. PubMed ID: 26812426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of IgG1 N-glycosylation on their interaction with Fc gamma receptors.
    Cambay F; Raymond C; Brochu D; Gilbert M; Tu TM; Cantin C; Lenferink A; Grail M; Henry O; De Crescenzo G; Durocher Y
    Curr Res Immunol; 2020 Dec; 1():23-37. PubMed ID: 35493857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.